Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[21] Characteristics and Patterns of Proton Pump Inhibitors Prescribing at the Primary Health Care
Stojakovic, Natasa
Jelic, Ana Golic
Satara, Svjetlana Stoisavljevic
Bednarcuk, Natasa
Stojiljkovic, Milos P.
Skrbic, Ranko
MEDICINA-LITHUANIA, 2022, 58 (11):
[22] Perceptions and Practices of Primary Care Physicians Regarding Proton Pump Inhibitors
Poushanchi, Behdod
Hadi, Yousaf
Roy, George
Vallabh, Hiren
Gayam, Swapna
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S646 - S646
[23] Effect of Proton Pump Inhibitors on the Discontinuation of Low-Dose Acetylsalicylic Acid in UK Primary Care
Martin-Merino, Elisa
Johansson, Saga
Garcia Rodriguez, Luis A.
GASTROENTEROLOGY, 2012, 142 (05) : S502 - S502
[24] Proton-pump inhibitors for acute peptic ulcer bleeding
Erstad, BL
ANNALS OF PHARMACOTHERAPY, 2001, 35 (06) : 730 - 740
[25] Proton pump inhibitors reduce risk of peptic ulcer rebleeding
Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (3): : 122 - 123
[26] Proton pump inhibitors and recurrent bleeding in peptic ulcer disease
Tajima, Akihiro
Koizumi, Kazuhito
Suzuki, Kazuyoshi
Higashi, Naoko
Takahashi, Morio
Shimada, Tadahito
Terano, Akira
Hiraishi, Hideyuki
Kuwayama, Hajime
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : S237 - S241
[27] Role of proton pump inhibitors in the management of peptic ulcer bleeding
Hwai-Jeng Lin
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2010, (02) : 51 - 53
[28] Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care
Garcia Rodriguez, Luis A.
Johansson, Saga
Nagy, Peter
Cea Soriano, Lucia
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (01) : 131 - 139
[29] Use of proton pump inhibitors and the risk of coronary events in patients receiving low-dose acetylsalicylic acid in UK primary care
Garcia Rodriguez, L. A.
Cea Soriano, L.
Bueno, H.
Lanas, A.
Johansson, S.
EUROPEAN HEART JOURNAL, 2012, 33 : 304 - 304
[30] Pathogenesis and treatment of acid peptic disorders: Comparison of proton pump inhibitors with other antiulcer agents
Sanders, SW
CLINICAL THERAPEUTICS, 1996, 18 (01) : 2 - 34

← 1 2 3 4 5 →